SRC-1 and SRC-3 have been reported to be overexpressed in PCa cell lines and clinical specimens, where their expression levels have been associated with tumor grade and disease-specific survival (Gnanapragasam et al. 2001, Lonard & O’Malley 2016). This evidence concerns the gene NCOA3 and neoplasm.